Log in to save to my catalogue

Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer’s disease phen...

Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer’s disease phen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ac5cf5dd51f14d3ba8d30c4735cde0de

Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer’s disease phenotype in mice

About this item

Full title

Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer’s disease phenotype in mice

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2023-10, Vol.133 (19), p.1-16

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Biological aging can be described as accumulative, prolonged metabolic stress and is the major risk factor for cognitive decline and Alzheimer's disease (AD). Recently, we identified and described a quinone reductase 2 (QR2) pathway in the brain, in which QR2 acts as a removable memory constraint and metabolic buffer within neurons. QR2 becomes ove...

Alternative Titles

Full title

Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer’s disease phenotype in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ac5cf5dd51f14d3ba8d30c4735cde0de

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ac5cf5dd51f14d3ba8d30c4735cde0de

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI162120

How to access this item